Related Experiment Video
Updated: Feb 2, 2026
05:52
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
Published on: June 30, 2011
20.4K
Insulin Pumping Patches: Emerging Insulin Delivery Systems
Bithika Thompson1, Curtiss B Cook1
11 Division of Endocrinology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Journal of Diabetes Science and Technology
|November 24, 2018
Summary
Patch pumps are innovative, tubing-free insulin delivery systems offering flexible options. This review covers available and developing patch pump technologies, patient data, and future trends in insulin therapy.
Area of Science:
- Biomedical Engineering
- Medical Devices
- Diabetes Technology
Background:
- Patch pumps represent a significant advancement in insulin delivery, offering a tubing-free, discreet, and user-friendly alternative to traditional insulin pumps.
- These novel systems are gaining traction in the diabetes management market due to their portability and ease of use.
Discussion:
- The current landscape of simple and complex patch pump systems available in the US market is examined.
- Technological underpinnings of existing patch pumps are detailed, alongside an exploration of emerging and promising innovations.
- Clinical trial data and patient preference studies related to patch pump usage are presented.
Key Insights:
- Patch pumps offer distinct advantages in flexibility, size, and weight compared to conventional insulin pumps.
- A comprehensive overview of current and developmental patch pump technologies provides valuable insights for healthcare professionals and patients.
- Patient-centric data highlights the growing acceptance and potential benefits of patch pump technology.
Outlook:
- The future trajectory of patch pump technology in diabetes care is discussed, considering ongoing research and development.
- Potential advancements may further enhance the capabilities and accessibility of insulin patch pumps.
- The evolving role of patch pumps in personalized diabetes management strategies is anticipated.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
736
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
736
01:05Insulin Secretory Vesicles
6.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.9K
01:28Insulin: The Receptor and Signaling Pathways
3.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.2K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.4K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.4K
01:16Insulin: Dosing Regimen and Adverse Effects
777
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
777
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.5K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.5K